Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
Bożena Adamczyk, Monika Adamczyk‐Sowa
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Top-down proteomic profiling of human saliva in multiple sclerosis patients
Barbara Manconi, Barbara Liori, Tiziana Cabras, et al.
Journal of Proteomics (2018) Vol. 187, pp. 212-222
Open Access | Times Cited: 51
Potential role of iron in repair of inflammatory demyelinating lesions
Nathanael J. Lee, Seung-Kwon Ha, Pascal Sati, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4365-4376
Open Access | Times Cited: 51
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Angela Dziedzic, Joanna Saluk, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5957-5957
Open Access | Times Cited: 48
Cellular Stress and General Pathological Processes
Eugeny Y. Gusev, Natalia V. Zotova
Current Pharmaceutical Design (2019) Vol. 25, Iss. 3, pp. 251-297
Closed Access | Times Cited: 43
Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study
Leda Mezzaroba, Andréa Name Colado Simão, Sayonara Rangel Oliveira, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2167-2178
Closed Access | Times Cited: 41
Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics
Nesma A.M. Ghonimi, Khaled A. Elsharkawi, Doaa S.M. Khyal, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 51, pp. 102941-102941
Closed Access | Times Cited: 38
New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration
Maria Podbielska, Joan O’Keeffe, Anna Pokryszko−Dragan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7319-7319
Open Access | Times Cited: 37
Neurodegeneration in Multiple Sclerosis: The Role of Nrf2-Dependent Pathways
Paloma P. Maldonado, Coram Guevara, Margrethe A. Olesen, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1146-1146
Open Access | Times Cited: 26
Vitamin D protects human melanocytes against oxidative damage by activation of Wnt/β-catenin signaling
Luyan Tang, Wei Fang, Jinran Lin, et al.
Laboratory Investigation (2018) Vol. 98, Iss. 12, pp. 1527-1537
Open Access | Times Cited: 46
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis
Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
Therapeutic Advances in Neurological Disorders (2019) Vol. 12, pp. 175628641881907-175628641881907
Open Access | Times Cited: 39
Neuroprotective Effects of Melatonin during Demyelination and Remyelination Stages in a Mouse Model of Multiple Sclerosis
Hanin Abdulbaset Abo Taleb, Badrah S. Alghamdi
Journal of Molecular Neuroscience (2019) Vol. 70, Iss. 3, pp. 386-402
Closed Access | Times Cited: 37
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
Michael Hecker, Jan Bühring, Brit Fitzner, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1510-1510
Open Access | Times Cited: 29
Piperine Improves Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats Through its Neuroprotective, Anti-inflammatory, and Antioxidant Effects
Reza Nasrnezhad, Sohrab Halalkhor, Farzin Sadeghi, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 11, pp. 5473-5493
Open Access | Times Cited: 28
In-silico studies of glutathione peroxidase4 activators as candidate for multiple sclerosis management
Alaa Alnoor Alameen, Mohnad Abdalla, Hanan M. Alshibl, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 6, pp. 101554-101554
Open Access | Times Cited: 20
Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results
Alessandra Vezzoli, Simona Mrakic‐Sposta, Cinzia Dellanoce, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1338-1338
Open Access | Times Cited: 11
Evaluation of the immune-modulatory, anti-oxidant, proliferative, and anti-apoptotic effects of nano-silymarin on mesenchymal stem cells isolated from multiple sclerosis patients' adipose tissue sources
Fahimeh Lavi Arab, Forouzan Yousefi, Mahmoud Reza Jaafari, et al.
Journal of Functional Foods (2024) Vol. 113, pp. 105958-105958
Open Access | Times Cited: 4
Whole-Body Cryostimulation in Multiple Sclerosis: A Scoping Review
Angelo Alito, Jacopo Maria Fontana, Eleonora Franzini Tibaldeo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2003-2003
Open Access | Times Cited: 4
Limosilactobacillus fermentum role in combination with human mesenchymal stem cell-derived secretome: A novel approach to alleviate inflammation in NASH pathogenesis
Seyedeh Kosar Mahmoudi, Shahrokh Abdolahi, Parastoo Saniee, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114686-114686
Closed Access
Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients
Kobra Bahrampour Juybari, Ghasem Ebrahimi, Mohammad Amin Momeni Moghaddam, et al.
Multiple Sclerosis and Related Disorders (2017) Vol. 19, pp. 79-84
Closed Access | Times Cited: 38
Modulating inflammation and neuroprotection in multiple sclerosis
Heather Yong, Gabrielle Chartier, Jacqueline A. Quandt
Journal of Neuroscience Research (2017) Vol. 96, Iss. 6, pp. 927-950
Closed Access | Times Cited: 35
Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis
Carin S. Waslo, Dennis Bourdette, Nora E. Gray, et al.
Current Treatment Options in Neurology (2019) Vol. 21, Iss. 6
Closed Access | Times Cited: 34
An overview of lipidomic analysis in different human matrices of multiple sclerosis
Helena Beatriz Ferreira, Bruna Neves, Inês M. S. Guerra, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 44, pp. 102189-102189
Closed Access | Times Cited: 31
The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
Bianca Vezzani, Marianna Carinci, Simone Patergnani, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1437-1437
Open Access | Times Cited: 31
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing—Remitting Multiple Sclerosis Mouse Model
Gabriele Di Sante, Susanna Amadio, Beatrice Sampaolese, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 748-748
Open Access | Times Cited: 29
Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors
Jong Hee Choi, Jinhee Oh, Min Jung Lee, et al.
Brain Behavior and Immunity (2020) Vol. 93, pp. 384-398
Closed Access | Times Cited: 28

Scroll to top